Jaguar Health (JAGX) Net Income towards Common Stockholders (2014 - 2026)

Jaguar Health (JAGX) has 13 years of Net Income towards Common Stockholders data on file, last reported at -$7.0 million in Q1 2026.

• On a quarterly basis, Net Income towards Common Stockholders rose 32.96% year-over-year to -$7.0 million in Q1 2026; TTM through Mar 2026 was -$50.4 million, a 25.38% decrease from a year earlier, with the FY2025 full-year figure at -$53.6 million, down 39.18% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at -$7.0 million, up from -$23.2 million in the prior quarter.
• Over the last five years, Net Income towards Common Stockholders for JAGX reached as high as -$7.0 million in Q1 2026 and fell as low as -$23.2 million in Q4 2025.
• Historically, Net Income towards Common Stockholders has averaged -$11.1 million across 5 years, with a median of -$10.0 million in 2024.
• Across the five-year window, Net Income towards Common Stockholders surged 47.03% in 2022 and plunged 126.63% in 2025, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at -$7.6 million in 2022, then slipped by 20.96% to -$9.2 million in 2023, then fell by 11.6% to -$10.2 million in 2024, then plunged by 126.63% to -$23.2 million in 2025, then surged by 69.75% to -$7.0 million in 2026.
• Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$7.0 million in Q1 2026, -$23.2 million in Q4 2025, and -$9.6 million in Q3 2025.